Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Toray Industries, Inc
Shanghai Junshi Bioscience Co., Ltd.
GI Innovation, Inc.
Eli Lilly and Company
GlaxoSmithKline
Nektar Therapeutics
National Institutes of Health Clinical Center (CC)